Home » Prices » NASDAQ:GRTX

Galera Therapeutics, Inc. stock price

Today's NASDAQ:GRTX chart, history & news

Price:
11.51 USD
Change:
+0.5 (4.54%)
Key Stats
Price open 11.15
Previous close 11.01
Market cap 286.39M
Volume 47.97K
Day high 11.61
Day low 11
Year high 19.5
Year low 5.58
Year to date change -16.14%
P/E Ratio -4.07
Company Profile
Fundamentals
Insider Information
News

About Galera Therapeutics, Inc.

Galera Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. The firm involves in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis and cancer. Its product candidate, GC4419, reduces severe oral mucositis in patients with head and neck cancer undergoing radiation therapy and also receiving cisplatin, a chemotherapy drug. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.

Company information

Company name
Galera Therapeutics, Inc.
Exchange
Sector
Health Technology
Industry
Pharmaceuticals: Major
Employees
32
CEO
J. Mel Sorensen
Address
2 West Liberty Boulevard, Malvern, PA, 19355
Country
United States
Contact information
1.610.725.1500
Website
http://www.galeratx.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.